U.S., Aug. 14 -- ClinicalTrials.gov registry received information related to the study (NCT07763145) titled 'Effect of Citicoline on Neurological Severity Score and Cerebral Doppler Resistive Index in Neonatal Hypoxic Ischemic Encephalopathy: A Randomized Control Trial' on Aug. 08.
Brief Summary: To determine the efficacy of citicoline in improving cerebral blood flow parameters and neurological status among neonates with hypoxic-ischemic encephalopathy using Doppler resistive index and Sarnat-Sarnat score after 72 hours of therapy.
Study Start Date: Sept. 01
Study Type: INTERVENTIONAL
Condition:
Hypoxic Ischaemic Encephalopathy (HIE)
Intervention:
DRUG: Citicoline
This group will receive drug and standard care
OTHER: Standard medi...